1.9 USD
-0.1 (-5%)
1.9039 USD
+0 (+0.21%)
VIVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. VIVS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VIVS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year VIVS was profitable.
- VIVS had a negative operating cash flow in the past year.
- In the past 5 years VIVS always reported negative net income.
- VIVS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- VIVS has a Return On Assets of -20.47%. This is in the better half of the industry: VIVS outperforms 76.00% of its industry peers.
- The Return On Equity of VIVS (-28.07%) is better than 77.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.47% | ||
| ROE | -28.07% | ||
| ROIC | N/A |
ROA(3y)-111.01%
ROA(5y)-81.92%
ROE(3y)-181.24%
ROE(5y)-124.91%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 98.57%, VIVS belongs to the best of the industry, outperforming 97.90% of the companies in the same industry.
- In the last couple of years the Gross Margin of VIVS has grown nicely.
- VIVS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 98.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y2.58%
2. Health
2.1 Basic Checks
- VIVS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, VIVS has less shares outstanding
- Compared to 5 years ago, VIVS has less shares outstanding
- There is no outstanding debt for VIVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -52.59, we must say that VIVS is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -52.59, VIVS is doing worse than 90.48% of the companies in the same industry.
- There is no outstanding debt for VIVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -52.59 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- VIVS has a Current Ratio of 3.10. This indicates that VIVS is financially healthy and has no problem in meeting its short term obligations.
- VIVS has a worse Current ratio (3.10) than 63.05% of its industry peers.
- A Quick Ratio of 3.10 indicates that VIVS has no problem at all paying its short term obligations.
- With a Quick ratio value of 3.10, VIVS is not doing good in the industry: 60.76% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.1 | ||
| Quick Ratio | 3.1 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 278.71% over the past year.
- Looking at the last year, VIVS shows a very strong growth in Revenue. The Revenue has grown by 35.92%.
- Measured over the past years, VIVS shows a very negative growth in Revenue. The Revenue has been decreasing by -42.03% on average per year.
EPS 1Y (TTM)278.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-589.48%
Revenue 1Y (TTM)35.92%
Revenue growth 3Y-54.21%
Revenue growth 5Y-42.03%
Sales Q2Q%-6.67%
3.2 Future
- The Earnings Per Share is expected to decrease by -6.30% on average over the next years.
- Based on estimates for the next years, VIVS will show a quite strong growth in Revenue. The Revenue will grow by 16.82% on average per year.
EPS Next Y2.6%
EPS Next 2Y-6.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.24%
Revenue Next 2Y16.82%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- VIVS is valuated cheaply with a Price/Earnings ratio of 0.99.
- VIVS's Price/Earnings ratio is rather cheap when compared to the industry. VIVS is cheaper than 99.81% of the companies in the same industry.
- VIVS is valuated cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
- The Forward Price/Earnings Ratio is negative for VIVS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.99 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- VIVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A cheap valuation may be justified as VIVS's earnings are expected to decrease with -6.30% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y-6.3%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- VIVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VIVOSIM LABS INC / VIVS FAQ
What is the ChartMill fundamental rating of VIVOSIM LABS INC (VIVS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to VIVS.
Can you provide the valuation status for VIVOSIM LABS INC?
ChartMill assigns a valuation rating of 4 / 10 to VIVOSIM LABS INC (VIVS). This can be considered as Fairly Valued.
What is the profitability of VIVS stock?
VIVOSIM LABS INC (VIVS) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for VIVS stock?
The Price/Earnings (PE) ratio for VIVOSIM LABS INC (VIVS) is 0.99 and the Price/Book (PB) ratio is 0.7.
What is the expected EPS growth for VIVOSIM LABS INC (VIVS) stock?
The Earnings per Share (EPS) of VIVOSIM LABS INC (VIVS) is expected to grow by 2.6% in the next year.